Zurich Insurance Group


Solid H1 20 figures in line with consensus expectations

13/08/20 -"• Net income attributable to shareholders decreased by 42% to $1.2bn for H1 20 • Estimated COVID-19 claims for FY2020 of $750m for P&C business were fully booked in H1 • The non-life combined ..."

Pages
51
Language
English
Published on
13/08/20
You may also be interested by these reports :
18/12/25
Storebrand has presented a convincing strategic plan at its CMD. While the group’s growth drivers are expected to remain broadly unchanged, we were ...

17/12/25
Uniqa’s recent CME conveyed a strong sense of optimism, and rightly so in our view. Beyond the formal upgrade of the FY28 targets, the key takeaways ...

17/12/25
Following Uniqa’s Capital Markets Event, we have reviewed our assumptions and are revising our SOTP valuation upwards. This reflects not only our ...

11/12/25
We are updating our assumptions on Helvetia Baloise following the publication of pro-forma accounts post-merger. The impacts are substantial on both ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO